# data[].attributes.headline
Malaria parasites have developed a resistance to drugs that already exist. Also if a certain drug kills off only one Malaria spreading organism, it still leaves other organisms to spread Malaria, though it may be at different rates. 

# data[].attributes.subject
Malaria parasites have developed a resistance to drugs that already exist. Also if a certain drug kills off only one Malaria spreading organism, it still leaves other organisms to spread Malaria, though it may be at different rates. 

# data[].attributes.body
Malaria kills an estimated 660,000 people each year.

# data[].attributes.body
Although effective antimalarials are currently available (BOX 1) that could be used in eradication campaigns, there are two major problems. The first is the potential emergence of resistance to artemisinin and its derivatives, which are the most effective drugs available today

# data[].attributes.headline
The malaria parasites are starting to produce resistance to the current anti-malarial drugs such as Aralen and Qualaquin. By develloping new anti-malarial drugs, it will stop the disease from spreading to more people.

# data[].attributes.subject
The malaria parasites are starting to produce resistance to the current anti-malarial drugs such as Aralen and Qualaquin. By develloping new anti-malarial drugs, it will stop the disease from spreading to more people.

# data[].attributes.headline
Current treatments appear to be ineffective

# data[].attributes.subject
Current treatments appear to be ineffective

# data[].attributes.body
Malaria elimination has recently been reinstated as a global health priority but current therapies seem to be insufficient for the task. Elimination efforts require new drug classes that alleviate symptoms, prevent transmission and provide a radical cure. To develop these next generation medicines, public-private partnerships are funding innovative approaches to identify compounds that target multiple parasite species at multiple stages of the parasite lifecycle.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941073/

# data[].attributes.body
The current anti-malarial drugs may have tto many side effects.
The side effects are:
www.nevdgp.org.au/info/travel/bots/antimalarial_se.htm

# data[].attributes.headline
Malaria parasite is developing resistance towards drugs used to treat the disease.

# data[].attributes.subject
Malaria parasite is developing resistance towards drugs used to treat the disease.

# data[].attributes.body
Mutations

# data[].attributes.body
The most common antimalarial drugs include and are slowly losing effectiveness.

Chloroquine (Aralen)

Quinine sulfate (Qualaquin)

Hydroxychloroquine (Plaquenil)

Mefloquine

Combination of atovaquone and proguanil (Malarone)

# data[].attributes.headline
The already existing drugs are losing effectiveness. This is because the plasmodium parasite that causes malaria is developing resistance to the current anti-malarial drugs.

# data[].attributes.subject
The already existing drugs are losing effectiveness. This is because the plasmodium parasite that causes malaria is developing resistance to the current anti-malarial drugs.

# data[].attributes.body
Outline the reasons for development of new anti-malarial drugs.